Search Orphan Drug Designations and Approvals
-
Generic Name: | (1S)-6-chloro-1,3,4,9-tetrahydro-1-(4-methoxyphenyl)-2H-pyrido[3,4-b]indole-2-carboxylic acid, 4-chlorophenyl ester |
---|---|
Date Designated: | 01/27/2020 |
Orphan Designation: | Treatment of Acute myeloid leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
PTC Therapeutics, Inc. 100 Corporate Court South Plainfield, New Jersey 07080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-